ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,746Medicare Part D Prescriptions Filled, Including Refills

Rank: 199 out of 2035

$989K Total Retail Price of All Prescriptions

Rank: 49 out of 2035

566 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
1% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

8% of this provider’s 566 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 9,268 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$101 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
SIMVASTATIN 577 551 1 1
LEVOTHYROXINE SODIUM 523 509 2 4
OMEPRAZOLE 294 285 3 5
LISINOPRIL 265 264 4 3
PRAVASTATIN SODIUM 251 244 5 17
AMLODIPINE BESYLATE 248 238 6 6
ATENOLOL 233 227 7 10
METOPROLOL SUCCINATE 223 217 8 16
ATORVASTATIN CALCIUM 216 199 9 13
LOSARTAN POTASSIUM 195 183 10 15
ZOLPIDEM TARTRATE 188 187 11 21
ZETIA 178 159 12 84
CRESTOR 177 167 13 41
HYDROCHLOROTHIAZIDE 166 164 14 12
METFORMIN HCL ER 127 124 15 78
LOSARTAN-HYDROCHLOROTHIAZIDE 119 110 16 47
ALENDRONATE SODIUM 114 112 17 27
CARVEDILOL 106 99 18 22
FLUTICASONE PROPIONATE 103 98 19 29
ACTOS 96 90 20 124
HYDROCODONE-ACETAMINOPHEN 95 87 S3 21 2
TAMSULOSIN HCL 94 82 22 25
SERTRALINE HCL 93 90 23 23
BISOPROLOL-HYDROCHLOROTHIAZIDE 91 79 24 189
GABAPENTIN 89 85 25 14
EVISTA 88 84 26 136
LISINOPRIL-HYDROCHLOROTHIAZIDE 83 82 27 26
ALLOPURINOL 81 81 28 34
CITALOPRAM HBR 76 76 29 20
CYMBALTA 72 67 30 59
TRIAMTERENE-HCTZ 70 70 31 35
TOPROL XL 68 65 32 354
TRAMADOL HCL-ACETAMINOPHEN 68 53 32 196
PRADAXA 67 67 34 242
POTASSIUM CHLORIDE 67 64 34 18
AMLODIPINE BESYLATE-BENAZEPRIL 63 54 36 88
METOPROLOL TARTRATE 63 60 36 8
DIOVAN HCT 62 62 38 126
VIVELLE-DOT 62 58 38 433
TRAMADOL HCL 61 58 40 19
TRILIPIX 61 49 40 244
TRAZODONE HCL 60 49 42 50
PAROXETINE HCL 60 55 42 69
GLIMEPIRIDE 60 56 42 55
CLOPIDOGREL 58 57 45 30
CELEBREX 58 52 45 104
CIPROFLOXACIN HCL 57 55 47 63
METFORMIN HCL 56 56 48 9
AMITRIPTYLINE HCL 55 55 R 49 101
ESTRADIOL 53 51 R 50 293
BENICAR 52 52 51 185
NAMENDA 51 51 52 37
VYTORIN 50 48 53 240
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 31, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.